Lam Research Corporation Reports Financial Results For The Q...| MENAFN.COM

Tuesday, 07 February 2023 11:13 GMT

Lam Research Corporation Reports Financial Results For The Quarter Ended December 25, 2022


(MENAFN- PR Newswire)

FREMONT, Calif., Jan. 25, 2023 /PRNewswire/ -- Lam Research Corporation (the 'Company,' 'Lam,' 'Lam Research') today announced financial results for the quarter ended December 25, 2022 (the 'December 2022 quarter').

Highlights for the December 2022 quarter were as follows:

  • Revenue of $5.28 billion.
  • U.S. GAAP gross margin of 45.0%, U.S. GAAP operating income as a percentage of revenue of 31.8%, and U.S. GAAP diluted EPS of $10.77.
  • Non-GAAP gross margin of 45.1%, non-GAAP operating income as a percentage of revenue of 32.1%, and non-GAAP diluted EPS of $10.71.

Key Financial Data for the Quarters Ended

December
25, 2022

and September
25, 2022

(in thousands, except per-share data, percentages, and basis points)



U.S. GAAP



December 2022


September 2022


Change Q/Q

Revenue


$



5,277,569


$



5,074,121


+ 4
%

Gross margin as percentage of revenue


45.0
%


46.1
%


- 110 bps

Operating income as percentage of revenue


31.8
%


33.5
%


- 170 bps

Diluted EPS


$





10.77


$





10.39


+ 3.7
%








Non-GAAP



December 2022


September 2022


Change Q/Q

Revenue


$



5,277,569


$



5,074,121


+ 4
%

Gross margin as percentage of revenue


45.1
%


46.0
%


- 90 bps

Operating income as percentage of revenue


32.1
%


33.3
%


- 120 bps

Diluted EPS


$





10.71


$





10.42


+ 2.8
%

U.S. GAAP Financial Results

For the December 2022 quarter, revenue was $5,278 million, gross margin was $2,376 million, or 45.0% of revenue, operating expenses were $696 million, operating income was 31.8% of revenue, and net income was $1,469 million, or $10.77 per diluted share on a U.S. GAAP basis. This compares to revenue of $5,074 million, gross margin of $2,337 million, or 46.1% of revenue, operating expenses of $639 million, operating income of 33.5% of revenue, and net income of $1,426 million, or $10.39 per diluted share, for the quarter ended September
25, 2022 (the 'September 2022 quarter').

Non-GAAP Financial Results

For the December 2022 quarter, non-GAAP gross margin was $2,382 million, or 45.1% of revenue, non-GAAP operating expenses were $686 million, non-GAAP operating income was 32.1% of revenue, and non-GAAP net income was $1,461 million, or $10.71 per diluted share. This compares to non-GAAP gross margin of $2,335 million, or 46.0% of revenue, non-GAAP operating expenses of $647 million, non-GAAP operating income of 33.3% of revenue, and non-GAAP net income of $1,429 million, or $10.42 per diluted share, for the September 2022 quarter.

'Lam closed out 2022 with record revenue and earnings per share for both the December quarter and calendar year, despite supply chain challenges and inflationary pressures,' said Tim Archer, Lam Research's President and Chief Executive Officer. 'Given the decline in wafer fabrication equipment spending expected in calendar year 2023, we are taking proactive steps to lower our cost structure and drive efficiencies across our global footprint, while preserving critical R&D. With these actions, Lam is focused on accelerating our strategic priorities to capitalize on the semiconductor industry's long-term growth prospects.'

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to $4.8 billion at the end of the December 2022 quarter compared to $4.6 billion at the end of the September 2022 quarter. This increase was primarily the result of $1,140 million of cash generated from operating activities, partially offset by
$456 million of share repurchases, including net share settlement of employee stock-based compensation; $236 million of dividends paid to stockholders; and $163 million of capital expenditures.

Deferred revenue at the end of the December 2022 quarter decreased to $1,984 million compared to $2,755 million as of the end of the September 2022 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $379 million as of December
25, 2022 and $401 million as of September
25, 2022.

Revenue

The geographic distribution of revenue during the December 2022 quarter is shown in the following table:

Region

Revenue

China

24
%

Korea

20
%

Taiwan

19
%

Japan

11
%

Southeast Asia

10
%

United States

10
%

Europe

6
%

The following table presents revenue disaggregated between system and customer support-related revenue:


Three Months Ended


December 25,
2022


September 25,
2022


December 26,
2021


(In thousands)

System revenue

$



3,547,518


$



3,181,987


$



2,740,173

Customer support-related revenue and other

1,730,051


1,892,134


1,486,431


$



5,277,569


$



5,074,121


$



4,226,604







System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.

Outlook

For the quarter ended March
26, 2023, Lam is providing the following guidance:


U.S. GAAP


Reconciling Items


Non-GAAP












Revenue

$3.8 Billion

+/-

$300 Million


-


$3.8 Billion

+/-

$300 Million

Gross margin as a percentage of revenue

42.8
%

+/-

1
%


$
45

Million


44.0
%

+/-

1
%

Operating income as a percentage of revenue

25.3
%

+/-

1
%


$
84

Million


27.5
%

+/-

1
%

Net income per diluted share

$5.95

+/-

$0.75


$
74

Million


$6.50

+/-

$0.75

Diluted share count

135 million


-


135 million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release, except as described below.
U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3 million; and restructuring charges, $42 million; totaling $45 million.
  • Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $4 million; and restructuring charges, $80 million; totaling $84 million.
  • Net income per diluted share - amortization related to intangible assets acquired though business combinations, $4 million; restructuring charges; $80 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($11 million); totaling $74 million.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the December 2022 and September 2022 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. Additionally, the non-GAAP results for the December 2022 quarter excludes a net income tax benefit associated with legal entity restructuring.

Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's website at .

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our expectations for wafer fabrication equipment spending; our cost structure and steps we are taking to lower it and drive efficiencies; our ability to preserve research and development; our ability to accelerate our strategic priorities; and the semiconductor industry's long-term growth prospects and our ability to capitalize on them. Some factors that may affect these forward-looking statements include: trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 26, 2022 and our quarterly report on Form 10-Q for the fiscal quarter ended September 25, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: lrcx ) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at . (LRCX-F)

Consolidated Financial Tables Follow.

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)

(unaudited)



Three Months Ended


Six Months Ended


December 25,
2022


September 25,
2022


December 26,
2021


December 25,
2022


December 26,
2021

Revenue

$
5,277,569


$
5,074,121


$
4,226,604


$ 10,351,690


$
8,531,069

Cost of goods sold

2,901,220


2,737,286


2,248,688


5,638,506


4,576,399

Gross margin

2,376,349


2,336,835


1,977,916


4,713,184


3,954,670

Gross margin as a percent of revenue

45.0
%


46.1
%


46.8
%


45.5
%


46.4
%

Research and development

462,385


433,375


403,644


895,760


785,971

Selling, general and administrative

233,802


205,620


236,133


439,422


458,327

Total operating expenses

696,187


638,995


639,777


1,335,182


1,244,298

Operating income

1,680,162


1,697,840


1,338,139


3,378,002


2,710,372

Operating income as a percent of revenue

31.8
%


33.5
%


31.7
%


32.6
%


31.8
%

Other income (expense), net

(28,234)


(43,095)


17,999


(71,329)


(10,858)

Income before income taxes

1,651,928


1,654,745


1,356,138


3,306,673


2,699,514

Income tax expense

(183,421)


(228,866)


(161,308)


(412,287)


(324,940)

Net income

$
1,468,507


$
1,425,879


$
1,194,830


$
2,894,386


$
2,374,574

Net income per share:










Basic

$

10.80


$

10.42


$


8.50


$


21.21


$


16.82

Diluted

$

10.77


$

10.39


$


8.44


$


21.16


$


16.71

Number of shares used in per share calculations:










Basic

136,018


136,891


140,630


136,455


141,187

Diluted

136,339


137,208


141,530


136,774


142,071

Cash dividend declared per common share

$

1.725


$

1.725


$


1.50


$


3.450


$


3.00











LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)



December 25,
2022


September 25,
2022


June 26,
2022


(unaudited)


(unaudited)


(1)

ASSETS






Cash and cash equivalents

$



4,484,716


$



4,256,499


$



3,522,001

Investments

103,130


120,551


135,731

Accounts receivable, net

4,070,088


4,569,735


4,313,818

Inventories

4,819,966


4,360,325


3,966,294

Prepaid expenses and other current assets

230,888


305,554


347,391

Total current assets

13,708,788


13,612,664


12,285,235

Property and equipment, net

1,863,155


1,718,791


1,647,587

Restricted cash and investments

251,344


250,955


251,534

Goodwill and intangible assets

1,805,218


1,624,932


1,616,963

Other assets

1,577,876


1,513,940


1,394,313

Total assets

$


19,206,381


$


18,721,282


$


17,195,632

LIABILITIES AND STOCKHOLDERS' EQUITY






Current portion of long-term debt and finance lease obligations

$

7,226


$

7,110


$

7,381

Other current liabilities

4,539,696


5,046,272


4,557,378

Total current liabilities

4,546,922


5,053,382


4,564,759

Long-term debt and finance lease obligations

4,996,057


4,996,363


4,998,449

Income taxes payable

862,405


840,214


931,117

Other long-term liabilities

496,362


418,756


422,941

Total liabilities

10,901,746


11,308,715


10,917,266

Stockholders' equity (2)

8,304,635


7,412,567


6,278,366

Total liabilities and stockholders' equity

$


19,206,381


$


18,721,282


$


17,195,632









(1)

Derived from audited financial statements.

(2)

Common shares issued and outstanding were 135,403 as of December
25, 2022, 136,374 as of September 25, 2022, and 136,975 as of
June 26, 2022.

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)



Three Months Ended


Six Months Ended


December 25,
2022


September 25,
2022


December 26,
2021


December 25,
2022


December 26,
2021

CASH FLOWS FROM OPERATING ACTIVITIES:










Net income

$

1,468,507


$

1,425,879


$

1,194,830


$

2,894,386


$

2,374,574

Adjustments to reconcile net income to net cash provided by operating activities:










Depreciation and amortization

85,414


75,751


81,705


161,165


161,579

Deferred income taxes

(6,680)


(133,616)


(13,550)


(140,296)


(26,573)

Equity-based compensation expense

73,084


71,110


62,834


144,194


120,933

Other, net

12,729


(2,751)


(66,514)


9,978


(75,204)

Changes in operating assets and liabilities

(492,867)


(246,785)


181,201


(739,652)


(657,279)

Net cash provided by operating activities

1,140,187


1,189,588


1,440,506


2,329,775


1,898,030

CASH FLOWS FROM INVESTING ACTIVITIES:










Capital expenditures and intangible assets

(163,378)


(140,063)


(138,493)


(303,441)


(274,920)

Business acquisitions, net of cash acquired

(119,955)


-


-


(119,955)


-

Net maturities and sales of available-for-sale securities

17,743


14,695


325,171


32,438


1,063,214

Other, net

(1,657)


(2,435)


(595)


(4,092)


(5,518)

Net cash (used for) provided by investing activities

(267,247)


(127,803)


186,083


(395,050)


782,776

CASH FLOWS FROM FINANCING ACTIVITIES:










Principal payments on debt

(17,082)


(1,854)


(1,698)


(18,936)


(8,036)

Treasury stock purchases

(456,276)


(109,779)


(414,815)


(566,055)


(1,651,568)

Dividends paid

(235,980)


(205,615)


(211,216)


(441,595)


(396,647)

Reissuance of treasury stock related to employee stock purchase plan

44,996


-


46,380


44,996


46,380

Proceeds from issuance of common stock

877


6,796


3,451


7,673


4,193

Other, net

1,253


(489)


(205)


764


(17)

Net cash used for financing activities

(662,212)


(310,941)


(578,103)


(973,153)


(2,005,695)

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

17,878


(16,925)


(4,678)


953


(8,454)

Net increase in cash, cash equivalents, and restricted cash

228,606


733,919


1,043,808


962,525


666,657

Cash, cash equivalents, and restricted cash at beginning of period

4,507,454


3,773,535


4,293,599


3,773,535


4,670,750

Cash, cash equivalents, and restricted cash at end of period

$

4,736,060


$

4,507,454


$

5,337,407


$

4,736,060


$

5,337,407











Non-GAAP Financial Summary

(in thousands, except percentages and per share data)

(unaudited)



Three Months Ended


December 25,
2022


September 25,
2022

Revenue

$

5,277,569


$

5,074,121

Gross margin

$

2,381,723


$

2,335,168

Gross margin as percentage of revenue

45.1
%


46.0
%

Operating expenses

$


686,348


$


647,239

Operating income

$

1,695,375


$

1,687,929

Operating income as a percentage of revenue

32.1
%


33.3
%

Net income

$

1,460,575


$

1,429,495

Net income per diluted share

$



10.71


$



10.42

Shares used in per share calculation - diluted

136,339


137,208

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(in thousands, except per share data)

(unaudited)



Three Months Ended


December 25,
2022


September 25,
2022

U.S. GAAP net income

$


1,468,507


$


1,425,879

Pre-tax non-GAAP items:




Amortization related to intangible assets acquired through certain business combinations - cost of goods sold

2,521


1,451

Elective deferred compensation ('EDC') related liability valuation increase (decrease) - cost of goods sold

2,853


(3,118)

EDC related liability valuation increase (decrease) - research and development

5,136


(5,612)

Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative

1,279


1,110

EDC related liability valuation increase (decrease) - selling, general and administrative

3,424


(3,742)

Amortization of note discounts - other income (expense), net

712


707

(Gain) loss on EDC related asset - other income (expense), net

(10,871)


12,726

Net income tax (benefit) expense on non-GAAP items

(1,213)


94

Net income tax benefit associated with legal entity restructuring

(11,773)


-

Non-GAAP net income

$


1,460,575


$


1,429,495

Non-GAAP net income per diluted share

$



10.71


$



10.42

U.S. GAAP net income per diluted share

$



10.77


$



10.39

U.S. GAAP and non-GAAP number of shares used for per diluted share calculation

136,339


137,208

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin,
Operating Expenses and Operating Income

(in thousands, except percentages)

(unaudited)



Three Months Ended


December 25,
2022


September 25,
2022

U.S. GAAP gross margin

$

2,376,349


$

2,336,835

Pre-tax non-GAAP items:




Amortization related to intangible assets acquired through certain business combinations

2,521


1,451

EDC related liability valuation increase (decrease)

2,853


(3,118)

Non-GAAP gross margin

$

2,381,723


$

2,335,168

U.S. GAAP gross margin as a percentage of revenue

45.0
%


46.1
%

Non-GAAP gross margin as a percentage of revenue

45.1
%


46.0
%

U.S. GAAP operating expenses

$


696,187


$


638,995

Pre-tax non-GAAP items:




Amortization related to intangible assets acquired through certain business combinations

(1,279)


(1,110)

EDC related liability valuation (increase) decrease

(8,560)


9,354

Non-GAAP operating expenses

$


686,348


$


647,239

U.S. GAAP operating income

$

1,680,162


$

1,697,840

Non-GAAP operating income

$

1,695,375


$

1,687,929

U.S. GAAP operating income as percent of revenue

31.8
%


33.5
%

Non-GAAP operating income as a percent of revenue

32.1
%


33.3
%

Lam Research Corporation Contacts:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: [email protected]

SOURCE Lam Research Corporation

MENAFN25012023003732001241ID1105477633


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.